Welcome To The Advanced Integrative Medical Science (AIMS) Institute
The Advanced Integrative Medical Science (AIMS) Institute is an outpatient clinic and research institute dedicated to advancing integrative medical care, research, and education within oncology, psychiatry, neurology, rehabilitation, pain, and palliative care.
Founded in 2018, we recognize the right of everyone to enjoy the benefits of scientific progress and its applications, and we are driven by the values of health and social justice.
We are making strides to improve the accessibility of our programs for all patients and support our community’s resilience and efficacy.
In line with our values, we hope to expand our services so everyone may enjoy their benefits. To see the list of insurers we accept by provider, visit our Insurance & Payments page.
Physicians Speak On A Multidisciplinary Approach To Healing
Physicians Speak On Cannabinoids
AIMS provides high-quality advanced integrative medical care for patients living with chronic and serious illness
First time visiting us? View our new patient guide.
meet Our Team
Meet our team of qualified health care providers and learn about our mission and values
What Our Patients Say
Latest Blog Posts
What the Cancer Community Actually Needs from Psychedelic Care
By Anne Hamilton, JD, MA When people talk about psychedelic therapy, the focus usually stays on depression, trauma, or neuroplasticity. These conversations matter, but they rarely touch the existential fear that defines the lives of people facing life-threatening illness. I write this not only as an attorney and psychedelic nonprofit executive director, but as someone who has lived this terrain myself as a cancer survivor. I was raised Catholic and grew up with a respect for ritual and mystery, even when filtered through institutions. My early life followed a logical sequence. I studied at Notre Dame, earned a master’s degree ...
Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis
https://scholarworks.seattleu.edu/dnp-projects/166/ The prevalences of Post-Traumatic Stress Disorder (PTSD), generalized anxiety disorder (GAD), and major depressive disorder (MDD) have risen significantly in recent years, particularly following the COVID-19 pandemic. Many individuals remain symptomatic despite conventional treatments, highlighting the need for novel, integrative interventions. Stellate Ganglion Block (SGB), a procedure targeting the cervical sympathetic chain to modulate the autonomic nervous system, has emerged as a promising therapy for treatment-resistant psychiatric symptoms. Evaluating data from the PTSD Checklist for DSM-5 (PCL-5), Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9), this retrospective study examined the clinical outcomes of PTSD, anxiety, and depression symptoms ...

